rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Illumina Innovation Fund II GP, L.L.C.

10% owner

Company insider

Files Form 4 as: 10% owner, Alamar Biosciences.

In numbers

Trades disclosed
26
Buys
1
Sells
0
Bought
$8.0M
Sold
$0
Companies
1
Companies where not an officer
1
First trade
20 Apr 2026
Last trade
20 Apr 2026
Last filed
20 Apr 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
ALMR Alamar Biosciences10% owner · Life-science tools · last 20 Apr 20261 buy · 0 sells

Activity over time

1 Apr – 1 Oct
01Apr 26Jun 26Jul 26Sep 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
20 Apr 2026filed 20 Apr 2026ALMR Alamar BiosciencesLife-science toolsSEC FORM 4 Code C—4,588,364filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar Biosciencesoption or derivative · Life-science toolsSEC FORM 4 Code C—2,094,266 at $0.00filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar Biosciencesoption or derivative · Life-science toolsSEC FORM 4 Code C—5,037,783 at $0.00filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar Biosciencesoption or derivative · Life-science toolsSEC FORM 4 Code C—filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar Biosciencesoption or derivative · Life-science toolsSEC FORM 4 Code C—filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar BiosciencesLife-science toolsSEC FORM 4 Code C—922,152filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar BiosciencesLife-science toolsSEC FORM 4 Code J—5,510,516filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar Biosciencesoption or derivative · Life-science toolsSEC FORM 4 Code C—3,194,377 at $0.00filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar Biosciencesoption or derivative · Life-science toolsSEC FORM 4 Code C—2,862,507 at $0.00filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar Biosciencesoption or derivative · Life-science toolsSEC FORM 4 Code C—2,094,266 at $0.00filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar Biosciencesoption or derivative · Life-science toolsSEC FORM 4 Code C—5,037,783 at $0.00filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar Biosciencesoption or derivative · Life-science toolsSEC FORM 4 Code C—filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar Biosciencesoption or derivative · Life-science toolsSEC FORM 4 Code C—filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar BiosciencesLife-science toolsSEC FORM 4 Code J—5,510,516filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar BiosciencesLife-science toolsSEC FORM 4 Code C—346,020filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar BiosciencesLife-science toolsSEC FORM 4 Code C—271,782filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar BiosciencesLife-science toolsSEC FORM 4 Bought$4.0M235,294 at $17.00filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar Biosciencesoption or derivative · Life-science toolsSEC FORM 4 Code C—3,194,377 at $0.00filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar BiosciencesLife-science toolsSEC FORM 4 Code C—4,588,364filing
20 Apr 2026filed 20 Apr 2026ALMR Alamar BiosciencesLife-science toolsSEC FORM 4 Code C—922,152filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care1

Buys in green, sells in red, by the company’s sector.

Related people

Qiming Corporate GP VI, Ltd.10% owner · 10% owner at Alamar Biosciences, filing Form 4 there in the last year
John L. BrottemGeneral Counsel · General Counsel at Alamar Biosciences, filing Form 4 there in the last year
Robert P. RagusaDirector · Director at Alamar Biosciences, filing Form 4 there in the last year
Justin J. McAnearChief Financial Officer · Chief Financial Officer at Alamar Biosciences, filing Form 4 there in the last year
Rebecca ChambersChief Financial Officer · Director at Alamar Biosciences, filing Form 4 there in the last year